We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Paper Strip Test Could Replace Current Pancreatic Cancer Tests

By LabMedica International staff writers
Posted on 23 Jul 2012
A new approach to clinical laboratory testing could eliminate the need for tissue biopsies to diagnose different types of cancer.

A 15-year-old high school student developed a diagnostic assay that experts say can be developed into medical laboratory test for the detection of pancreatic cancer. More...
The teen’s prize-winning breakthrough test could change how cancer and other fatal diseases are diagnosed and treated.

The new approach to detecting pancreatic cancer is noninvasive, so it does not require a biopsy specimen. It is also inexpensive and fast. At a cost of about USD 3 per test, the diagnostic assay produces a result in five minutes. The detection device was a USD 50 electric meter from a home ware store. The student observed that this diagnostic test would also work with an ordinary diabetes meter.

The student, Jack Andraka, created a clinical laboratory test that uses filter paper dipped into a solution of carbon nanotubes (CN). It detects the levels of mesothelin in blood or urine. Mesothelin is a protein biomarker for pancreatic cancer

“It’s really crucial to detect [pancreatic, lung, and ovarian cancers] in their early stages where survival rates are at their highest,” Jack Andraka declared. “I focused specifically on pancreatic cancer […] due to its extremely low survival rates.”

The test can be adapted to monitor resistance to antibiotics and to follow the progression of treatment of cancer patients undergoing chemotherapy or radiation.

Related Links:

National Cancer Institute




Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.